Cellebrite Q1 EPS Tops by $0.06, 19% Revenue Growth Triggers 4% Slide
Cellebrite posted adjusted EPS of $0.12 in Q1, beating estimates by $0.06, as revenue rose 19% to $128.3 million and ARR climbed 21% to $493 million. Shares fell over 4% after the company guided Q2 ARR of $510–513 million and revenue of $130–133 million.
1. First-Quarter Financial Results
Cellebrite delivered adjusted earnings per share of $0.12 in Q1, surpassing analyst forecasts by $0.06. Total revenue climbed 19% year-on-year to $128.3 million, driven by subscription revenue of $117.9 million and annual recurring revenue reaching $493.0 million.
2. Share Reaction and Market Sentiment
Despite the stronger quarterly performance, shares slid over 4% in premarket trading as investors focused on the cautious near-term outlook. Market participants weighed the earnings beat against the guidance range for the upcoming quarter.
3. Second-Quarter Outlook
The company projected Q2 ARR between $510 million and $513 million, implying roughly 22.5% annual growth, and revenue of $130 million to $133 million, suggesting about 16% year-on-year expansion. This guidance tempered optimism following the first-quarter beat.
4. Full-Year Guidance and Profitability
For full-year 2026, Cellebrite forecasts ARR of $567 million to $573 million and revenue of $565 million to $571 million, targeting approximately 19.5% growth. First-quarter adjusted EBITDA was $30.6 million (23.9% margin), and trailing 12-month free cash flow totaled $158.6 million (32% margin).